The interplay between oral microbiota, gut microbiota and systematic diseases

References

• Rinninella E, Raoul P, Cintoni M, et al. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms. 2019;7:7.
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027–16.
   PubMed Web of Science ®Google Scholar
• Mojsak P, Rey-Stolle F, Parfieniuk E, et al. The role of gut microbiota (GM) and GM-related metabolites in diabetes and obesity. A review of analytical methods used to measure GM-related metabolites in fecal samples with a focus on metabolites’ derivatization step. J Pharm Biomed Anal. 2020;191:113617.
   PubMed Web of Science ®Google Scholar
• Maeda Y, Takeda K. Role of gut microbiota in rheumatoid arthritis. J Clin Med. 2017;6:6.
   PubMed Web of Science ®Google Scholar
• Sundin J, Ohman L, Simren M. Understanding the gut microbiota in inflammatory and functional gastrointestinal diseases. Psychosom Med. 2017;79:857–867.
   PubMed Web of Science ®Google Scholar
• Kilian M, Chapple IL, Hannig M, et al. The oral microbiome - an update for oral healthcare professionals. Br Dent J. 2016;221:657–666.
   PubMed Web of Science ®Google Scholar
• Wang J, Jia Z, Zhang B, et al. Tracing the accumulation of in vivo human oral microbiota elucidates microbial community dynamics at the gateway to the GI tract. Gut. 2020;69:1355–1356.
   PubMed Web of Science ®Google Scholar
• Kitamoto S, Kamada N. Untangling the oral-gut axis in the pathogenesis of intestinal inflammation. Int Immunol. 2022;34:485–490.
   PubMed Web of Science ®Google Scholar
• Kitamoto S, Kamada N. Periodontal connection with intestinal inflammation: microbiological and immunological mechanisms. Periodontol 2000. 2022;89:142–153.
   PubMed Web of Science ®Google Scholar
• Kitamoto S, Nagao-Kitamoto H, Hein R, et al. The bacterial connection between the oral cavity and the gut diseases. J Dent Res. 2020;99:1021–1029.
   PubMed Web of Science ®Google Scholar
• Humphrey SP, Williamson RT. A review of saliva: normal composition, flow, and function. J Prosthet Dent. 2001;85:162–169.
   PubMed Web of Science ®Google Scholar
• Bao J, Li L, Zhang Y, et al. Periodontitis may induce gut microbiota dysbiosis via salivary microbiota. Int J Oral Sci. 2022;14:32.
   PubMed Web of Science ®Google Scholar
• Rashidi A, Ebadi M, Weisdorf DJ, et al. No evidence for colonization of oral bacteria in the distal gut in healthy adults. Proc Natl Acad Sci U S A. 2021:118. DOI:10.1073/pnas.2114152118.
   Google Scholar
• Schmidt TS, Hayward MR, Coelho LP, et al. Extensive transmission of microbes along the gastrointestinal tract. Elife. 2019;8. doi:10.7554/eLife.42693.
   Web of Science ®Google Scholar
• Mall AS, Habte H, Mthembu Y, et al. Mucus and Mucins: do they have a role in the inhibition of the human immunodeficiency virus? Virol J. 2017;14:192.
   PubMed Web of Science ®Google Scholar
• Li L, Bao J, Chang Y, et al. Gut microbiota may mediate the influence of periodontitis on prediabetes. J Dent Res. 2021;100:1387–1396.
   PubMed Web of Science ®Google Scholar
• Qian J, Lu J, Huang Y, et al. Periodontitis salivary microbiota worsens colitis. J Dent Res. 2022;101:559–568.
   PubMed Web of Science ®Google Scholar
• Lu J, Zhang S, Huang Y, et al. Periodontitis-related salivary microbiota aggravates Alzheimer’s disease via gut-brain axis crosstalk. Gut Microbes. 2022;14:2126272.
   PubMed Web of Science ®Google Scholar
• Wang N, Zheng L, Qian J, et al. Salivary microbiota of periodontitis aggravates bone loss in ovariectomized rats. Front Cell Infect Microbiol. 2022;12:983608.
   PubMed Web of Science ®Google Scholar
• Boutaga K, Savelkoul PH, Winkel EG, et al. Comparison of subgingival bacterial sampling with oral lavage for detection and quantification of periodontal pathogens by real-time polymerase chain reaction. J Periodontol. 2007;78:79–86.
   PubMed Web of Science ®Google Scholar
• He J, Huang W, Pan Z, et al. Quantitative analysis of microbiota in saliva, supragingival, and subgingival plaque of Chinese adults with chronic periodontitis. Clin Oral Investig. 2012;16:1579–1588.
   PubMed Web of Science ®Google Scholar
• Saygun I, Nizam N, Keskiner I, et al. Salivary infectious agents and periodontal disease status. J Periodontal Res. 2011;46:235–239.
   PubMed Web of Science ®Google Scholar
• Arimatsu K, Yamada H, Miyazawa H, et al. Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota. Sci Rep. 2014;4:4828.
   PubMed Web of Science ®Google Scholar
• Liu Y, Huang W, Dai K, et al. Inflammatory response of gut, spleen, and liver in mice induced by orally administered Porphyromonas gingivalis. J Oral Microbiol. 2022;14:2088936.
   PubMed Web of Science ®Google Scholar
• Nakajima M, Arimatsu K, Kato T, et al. Oral administration of P. gingivalis induces dysbiosis of gut microbiota and impaired barrier function leading to dissemination of enterobacteria to the liver. PLoS ONE. 2015;10:e0134234.
   PubMed Web of Science ®Google Scholar
• Parahitiyawa NB, Jin LJ, Leung WK, et al. Microbiology of odontogenic bacteremia: beyond endocarditis. Clin Microbiol Rev. 2009;22:46–64.
   PubMed Web of Science ®Google Scholar
• Lockhart PB, Brennan MT, Sasser HC, et al. Bacteremia associated with toothbrushing and dental extraction. Circulation. 2008;117:3118–3125.
   PubMed Web of Science ®Google Scholar
• Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol. 2015;15:30–44.
   PubMed Web of Science ®Google Scholar
• Abed J, Maalouf N, Manson AL, et al. Colon cancer-associated Fusobacterium nucleatum may originate from the oral cavity and reach colon tumors via the circulatory system. Front Cell Infect Microbiol. 2020;10:400.
   PubMedGoogle Scholar
• Morton AM, Sefik E, Upadhyay R, et al. Endoscopic photoconversion reveals unexpectedly broad leukocyte trafficking to and from the gut. Proc Natl Acad Sci U S A. 2014;111:6696–6701.
   PubMed Web of Science ®Google Scholar
• Kitamoto S, Nagao-Kitamoto H, Jiao Y, et al. The intermucosal connection between the mouth and gut in commensal pathobiont-driven colitis. Cell 2020. 182:447–462 e414.10.1016/j.cell.2020.05.048
   Google Scholar
• Komazaki R, Katagiri S, Takahashi H, et al. Periodontal pathogenic bacteria, Aggregatibacter actinomycetemcomitans affect non-alcoholic fatty liver disease by altering gut microbiota and glucose metabolism. Sci Rep. 2017;7:13950.
   PubMed Web of Science ®Google Scholar
• Haraga H, Sato T, Watanabe K, et al. Effect of the progression of Fusobacterium nucleatum–induced apical periodontitis on the gut microbiota. J Endod. 2022;48:1038–1045.
   PubMed Web of Science ®Google Scholar
• Kobayashi R, Ogawa Y, Hashizume-Takizawa T, et al. Oral bacteria affect the gut microbiome and intestinal immunity. Pathog Dis. 2020;78:78.
   Web of Science ®Google Scholar
• Hajishengallis G, Liang S, Payne MA, et al. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe. 2011;10:497–506.
   PubMed Web of Science ®Google Scholar
• Kim S, Bando Y, Chang C, et al. Topical application of Porphyromonas gingivalis into the gingival pocket in mice leads to chronic-active infection, periodontitis and systemic inflammation. Int J Mol Med. 2022:50. DOI:10.3892/ijmm.2022.5159.
   Google Scholar
• Simas AM, Kramer CD, Weinberg EO, et al. Oral infection with a periodontal pathogen alters oral and gut microbiomes. Anaerobe. 2021;71:102399.
   PubMed Web of Science ®Google Scholar
• Sato K, Takahashi N, Kato T, et al. Aggravation of collagen-induced arthritis by orally administered Porphyromonas gingivalis through modulation of the gut microbiota and gut immune system. Sci Rep. 2017;7:6955.
   PubMed Web of Science ®Google Scholar
• Li B, Ge Y, Cheng L, et al. Oral bacteria colonize and compete with gut microbiota in gnotobiotic mice. Int J Oral Sci. 2019;11:10.
   PubMed Web of Science ®Google Scholar
• Kramer CD, Simas AM, He X, et al. Distinct roles for dietary lipids and Porphyromonas gingivalis infection on atherosclerosis progression and the gut microbiota. Anaerobe. 2017;45:19–30.
   PubMed Web of Science ®Google Scholar
• Sato K, Yokoji M, Yamada M, et al. An orally administered oral pathobiont and commensal have comparable and innocuous systemic effects in germ-free mice. J Periodontal Res. 2018;53:950–960.
   PubMed Web of Science ®Google Scholar
• Sasaki N, Katagiri S, Komazaki R, et al. Endotoxemia by porphyromonas gingivalis injection aggravates non-alcoholic fatty liver disease, disrupts glucose/lipid metabolism, and alters gut microbiota in mice. Front Microbiol. 2018;9:2470.
   PubMed Web of Science ®Google Scholar
• Kato T, Yamazaki K, Nakajima M, et al. Oral administration of porphyromonas gingivalis alters the gut microbiome and serum metabolome. mSphere. 2018;3:3.
   Web of Science ®Google Scholar
• Ohtsu A, Takeuchi Y, Katagiri S, et al. Influence of Porphyromonas gingivalis in gut microbiota of streptozotocin-induced diabetic mice. Oral Dis. 2019: 25:868–880. DOI:10.1111/odi.13044.
   PubMed Web of Science ®Google Scholar
• Watanabe K, Katagiri S, Takahashi H, et al. Porphyromonas gingivalis impairs glucose uptake in skeletal muscle associated with altering gut microbiota. FASEB J. 2021;35:e21171.
   PubMed Web of Science ®Google Scholar
• Hamamoto Y, Ouhara K, Munenaga S, et al. Effect of Porphyromonas gingivalis infection on gut dysbiosis and resultant arthritis exacerbation in mouse model. Arthritis Res Ther. 2020;22:249.
   PubMedGoogle Scholar
• Yamazaki K, Sato K, Tsuzuno T, et al. Orally administered pathobionts and commensals have comparable and innocuous systemic effects on germ-free mice. Microb Pathog. 2020;140:103962.
   PubMed Web of Science ®Google Scholar
• Simas AM, Kramer CD, Genco CA. Diet-induced non-alcoholic fatty liver disease and associated gut dysbiosis are exacerbated by oral infection. Front Oral Health. 2021;2:784448.
   PubMedGoogle Scholar
• Yamazaki K, Kato T, Tsuboi Y, et al. Oral pathobiont-induced changes in gut microbiota aggravate the pathology of nonalcoholic fatty liver disease in mice. Front Immunol. 2021;12:766170.
   PubMed Web of Science ®Google Scholar
• Fine DH, Patil AG, Velusamy SK. Aggregatibacter actinomycetemcomitans (Aa) under the radar: myths and misunderstandings of aa and its role in aggressive periodontitis. Front Immunol. 2019;10:728.
   PubMed Web of Science ®Google Scholar
• Zhong Y, Nyman M, Fak F. Modulation of gut microbiota in rats fed high-fat diets by processing whole-grain barley to barley malt. Mol Nutr Food Res. 2015;59:2066–2076.
   PubMed Web of Science ®Google Scholar
• Vrieze A, Van Nood E, Holleman F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012;143:913–916 e917.
   PubMed Web of Science ®Google Scholar
• Branchereau M, Reichardt F, Loubieres P, et al. Periodontal dysbiosis linked to periodontitis is associated with cardiometabolic adaptation to high-fat diet in mice. Am J Physiol Gastr Liver Physiol. 2016;310:G1091–1101.
   PubMed Web of Science ®Google Scholar
• Xiao E, Mattos M, Vieira GHA, et al. Diabetes enhances IL-17 expression and alters the oral microbiome to increase its pathogenicity. Cell Host Microbe. 2017;22:120–128 e124.
   PubMed Web of Science ®Google Scholar
• Botelho J, Mascarenhas P, Viana J, et al. An umbrella review of the evidence linking oral health and systemic noncommunicable diseases. Nat Commun. 2022;13:7614.
   PubMed Web of Science ®Google Scholar
• Meurman JH, Bascones-Martinez A. Oral infections and systemic health - more than just links to cardiovascular diseases. Oral Health Prev Dent. 2021;19:441–448.
   PubMed Web of Science ®Google Scholar
• Lee YH, Chung SW, Auh QS, et al. Progress in oral microbiome related to oral and systemic diseases: an update. Diagnostics (Basel). 2021;11:1283.
   PubMedGoogle Scholar
• Graves DT, Correa JD, Silva TA. The oral microbiota is modified by systemic diseases. J Dent Res. 2019;98:148–156.
   PubMed Web of Science ®Google Scholar
• Jia G, Zhi A, Lai PFH, et al. The oral microbiota - a mechanistic role for systemic diseases. Br Dent J. 2018;224:447–455.
   PubMed Web of Science ®Google Scholar
• Sampaio-Maia B, Caldas IM, Pereira ML, et al. The oral microbiome in health and its implication in oral and systemic diseases. Adv Appl Microbiol. 2016;97:171–210.
   PubMed Web of Science ®Google Scholar
• Tavares M, Lindefjeld Calabi KA, San Martin L. Systemic diseases and oral health. Dent Clin North Am 2014. 58:797–814. DOI:10.1016/j.cden.2014.07.005.
   Google Scholar
• Inaba H, Amano A. Roles of oral bacteria in cardiovascular diseases–from molecular mechanisms to clinical cases: implication of periodontal diseases in development of systemic diseases. J Pharmacol Sci. 2010;113:103–109.
   PubMed Web of Science ®Google Scholar
• Chen BY, Lin WZ, Li YL, et al. Roles of oral microbiota and oral-gut microbial transmission in hypertension. J Adv Res. 2023;43:147–161.
   PubMed Web of Science ®Google Scholar
• Liu F, Su D, Zhang H, et al. Clinical implications of the oral‑gut microbiome axis and its association with colorectal cancer (Review). Oncol Rep. 2022;48:48.
   Web of Science ®Google Scholar
• Lam GA, Albarrak H, McColl CJ, et al. The oral-gut axis: periodontal diseases and gastrointestinal disorders. Inflamm Bowel Dis. 2022. DOI:10.1093/ibd/izac241.
   PubMed Web of Science ®Google Scholar
• Albuquerque-Souza E, Sahingur SE. Periodontitis, chronic liver diseases, and the emerging oral-gut-liver axis. Periodontol 2000. 2022;89:125–141.
   PubMed Web of Science ®Google Scholar
• Sansores-Espana LD, Melgar-Rodriguez S, Olivares-Sagredo K, et al. Oral-gut-brain axis in experimental models of periodontitis: associating gut dysbiosis with neurodegenerative diseases. Front Aging. 2021;2:781582.
   PubMedGoogle Scholar
• Byrd KM, Gulati AS. The “gum-gut” axis in inflammatory bowel diseases: a hypothesis-driven review of associations and advances. Front Immunol. 2021;12:620124.
   PubMed Web of Science ®Google Scholar
• Kunath BJ, Hickl O, Queiros P, et al. Alterations of oral microbiota and impact on the gut microbiome in type 1 diabetes mellitus revealed by integrated multi-omic analyses. Microbiome. 2022;10:243.
   PubMed Web of Science ®Google Scholar
• Dong Z, Lv W, Zhang C, et al. Correlation analysis of gut microbiota and serum metabolome with porphyromonas gingivalis-induced metabolic disorders. Front Cell Infect Microbiol. 2022;12:858902.
   PubMed Web of Science ®Google Scholar
• Kashiwagi Y, Aburaya S, Sugiyama N, et al. Porphyromonas gingivalis induces entero-hepatic metabolic derangements with alteration of gut microbiota in a type 2 diabetes mouse model. Sci Rep. 2021;11:18398.
   PubMed Web of Science ®Google Scholar
• Shen X, Wei H, Li J, et al. Ectopic colonization and immune landscapes of periodontitis microbiota in germ-free mice with streptozotocin-induced type 1 diabetes mellitus. Front Microbiol. 2022;13:889415.
   PubMed Web of Science ®Google Scholar
• Tsuzuno T, Takahashi N, Yamada-Hara M, et al. Ingestion of Porphyromonas gingivalis exacerbates colitis via intestinal epithelial barrier disruption in mice. J Periodontal Res. 2021;56:275–288.
   PubMed Web of Science ®Google Scholar
• Flak MB, Colas RA, Munoz-Atienza E, et al. Inflammatory arthritis disrupts gut resolution mechanisms, promoting barrier breakdown by Porphyromonas gingivalis. JCI Insight. 2019;4:4.
   Web of Science ®Google Scholar
• Cao P, Chen Y, Guo X, et al. Fusobacterium nucleatum activates endoplasmic reticulum stress to promote crohn’s disease development via the upregulation of CARD3 expression. Front Pharmacol. 2020;11:106.
   PubMed Web of Science ®Google Scholar
• Vaarala O, Atkinson MA, Neu J. The “perfect storm” for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes. 2008;57:2555–2562.
   PubMed Web of Science ®Google Scholar
• Abdelmalek MF. Nonalcoholic fatty liver disease: another leap forward. Nat Rev Gastroenterol Hepatol. 2021;18:85–86.
   PubMed Web of Science ®Google Scholar
• Cotter TG, Rinella M. Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology. 2020;158:1851–1864.
   PubMed Web of Science ®Google Scholar
• Day CP, James OF. Steatohepatitis: a tale of two “hits”? Gastroenterology. 1998;114:842–845.
   PubMed Web of Science ®Google Scholar
• Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. 2016;65:1038–1048.
   PubMed Web of Science ®Google Scholar
• Kuraji R, Sekino S, Kapila Y, et al. Periodontal disease-related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: an emerging concept of oral-liver axis. Periodontol 2000. 2021;87:204–240.
   PubMed Web of Science ®Google Scholar
• Furusho H, Miyauchi M, Hyogo H, et al. Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice. J Gastroenterol. 2013;48:1259–1270.
   PubMed Web of Science ®Google Scholar
• Kuraji R, Ito H, Fujita M, et al. Porphyromonas gingivalis induced periodontitis exacerbates progression of non-alcoholic steatohepatitis in rats. Clin Exp Dent Res. 2016;2:216–225.
   PubMedGoogle Scholar
• Ni J, Chen L, Zhong S, et al. Influence of periodontitis and scaling and root planing on insulin resistance and hepatic CD36 in obese rats. J Periodontol. 2018;89:476–485.
   PubMed Web of Science ®Google Scholar
• Nagasaki A, Sakamoto S, Chea C, et al. Odontogenic infection by Porphyromonas gingivalis exacerbates fibrosis in NASH via hepatic stellate cell activation. Sci Rep. 2020;10:4134.
   PubMed Web of Science ®Google Scholar
• Nagasaki A, Sakamoto S, Arai T, et al. Elimination of Porphyromonas gingivalis inhibits liver fibrosis and inflammation in NASH. J Clin Periodontol. 2021;48:1367–1378.
   PubMed Web of Science ®Google Scholar
• Fujita M, Kuraji R, Ito H, et al. Histological effects and pharmacokinetics of lipopolysaccharide derived from Porphyromonas gingivalis on rat maxilla and liver concerning with progression into non-alcoholic steatohepatitis. J Periodontol. 2018;89:1101–1111.
   PubMed Web of Science ®Google Scholar
• Ishikawa M, Yoshida K, Okamura H, et al. Oral Porphyromonas gingivalis translocates to the liver and regulates hepatic glycogen synthesis through the Akt/GSK-3beta signaling pathway. Biochim Biophys Acta. 2013;1832:2035–2043.
   PubMed Web of Science ®Google Scholar
• Thibaut R, Gage MC, Pineda-Torra I, et al. Liver macrophages and inflammation in physiology and physiopathology of non-alcoholic fatty liver disease. FEBS J. 2022;289:3024–3057.
   PubMed Web of Science ®Google Scholar
• Matsuda Y, Kato T, Takahashi N, et al. Ligature-induced periodontitis in mice induces elevated levels of circulating interleukin-6 but shows only weak effects on adipose and liver tissues. J Periodontal Res. 2016;51:639–646.
   PubMed Web of Science ®Google Scholar
• Kim EJ, Kim BH, Seo HS, et al. Cholesterol-induced non-alcoholic fatty liver disease and atherosclerosis aggravated by systemic inflammation. PLoS ONE. 2014;9:e97841.
   PubMed Web of Science ®Google Scholar
• Gupta H, Min BH, Ganesan R, et al. Gut microbiome in non-alcoholic fatty liver disease: from mechanisms to therapeutic role. Biomedicines. 2022;10:10.
   Web of Science ®Google Scholar
• Madatali Abuwani A, Priyadarshini Dash S, Ganesan R, et al. Gut microbiome and metabolic response in non-alcoholic fatty liver disease. Clin Chim Acta. 2021;523:304–314.
   PubMed Web of Science ®Google Scholar
• Safari Z, Gerard P. The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD). Cell Mol Life Sci. 2019;76:1541–1558.
   PubMed Web of Science ®Google Scholar
• McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365:2205–2219.
   PubMed Web of Science ®Google Scholar
• Wegner N, Lundberg K, Kinloch A, et al. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol Rev. 2010;233:34–54.
   PubMed Web of Science ®Google Scholar
• Wegner N, Wait R, Sroka A, et al. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and alpha-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum. 2010;62:2662–2672.
   PubMed Web of Science ®Google Scholar
• Kitamura K, Shionoya H, Suzuki S, et al. Oral and intestinal bacterial substances associated with disease activities in patients with rheumatoid arthritis: a cross-sectional clinical study. J Immunol Res 2022. 2022;2022:6839356.
   Google Scholar
• Chukkapalli S, Rivera-Kweh M, Gehlot P, et al. Periodontal bacterial colonization in synovial tissues exacerbates collagen-induced arthritis in B10.RIII mice. Arthritis Res Ther 2016. 18:161.10.1186/s13075-016-1056-4
   Google Scholar
• Maresz KJ, Hellvard A, Sroka A, et al. Porphyromonas gingivalis facilitates the development and progression of destructive arthritis through its unique bacterial peptidylarginine deiminase (PAD). PLOS Pathog. 2013;9:e1003627.
   PubMed Web of Science ®Google Scholar
• Marchesan JT, Gerow EA, Schaff R, et al. Porphyromonas gingivalis oral infection exacerbates the development and severity of collagen-induced arthritis. Arthritis Res Ther. 2013;15(6):R186. DOI:10.1186/ar4376
   PubMed Web of Science ®Google Scholar
• Jung H, Jung SM, Rim YA, et al. Arthritic role of Porphyromonas gingivalis in collagen-induced arthritis mice. PLoS ONE. 2017;12:e0188698.
   PubMed Web of Science ®Google Scholar
• Yamakawa M, Ouhara K, Kajiya M, et al. Porphyromonas gingivalis infection exacerbates the onset of rheumatoid arthritis in SKG mice. Clin Exp Immunol. 2016;186:177–189.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang D, Jia H, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med. 2015;21:895–905.
   PubMed Web of Science ®Google Scholar
• Cohen LJ, Cho JH, Gevers D, et al. Genetic factors and the intestinal microbiome guide development of microbe-based therapies for inflammatory bowel diseases. Gastroenterology. 2019;156:2174–2189.
   PubMed Web of Science ®Google Scholar
• Xun Z, Zhang Q, Xu T, et al. Dysbiosis and ecotypes of the salivary microbiome associated with inflammatory bowel diseases and the assistance in diagnosis of diseases using oral bacterial profiles. Front Microbiol. 2018;9:1136.
   PubMed Web of Science ®Google Scholar
• Shin NR, Whon TW, Bae JW. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 2015;33:496–503.
   PubMed Web of Science ®Google Scholar
• Atarashi K, Suda W, Luo C, et al. Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation. Science. 2017;358:359–365.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30.
   PubMed Web of Science ®Google Scholar
• Fan X, Alekseyenko AV, Wu J, et al. Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study. Gut. 2018;67:120–127.
   PubMed Web of Science ®Google Scholar
• Michaud DS, Izard J, Wilhelm-Benartzi CS, et al. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. Gut. 2013;62:1764–1770.
   PubMed Web of Science ®Google Scholar
• Matsukawa H, Iida N, Kitamura K, et al. Dysbiotic gut microbiota in pancreatic cancer patients form correlation networks with the oral microbiota and prognostic factors. Am J Cancer Res. 2021;11:3163–3175.
   PubMed Web of Science ®Google Scholar
• Gaiser RA, Halimi A, Alkharaan H, et al. Enrichment of oral microbiota in early cystic precursors to invasive pancreatic cancer. Gut. 2019;68:2186–2194.
   PubMed Web of Science ®Google Scholar
• Tan Q, Ma X, Yang B, et al. Periodontitis pathogen Porphyromonas gingivalis promotes pancreatic tumorigenesis via neutrophil elastase from tumor-associated neutrophils. Gut Microbes. 2022;14:2073785.
   PubMed Web of Science ®Google Scholar
• Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019;16:713–732.
   PubMed Web of Science ®Google Scholar
• Zeller G, Tap J, Voigt AY, et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol. 2014;10:766.
   PubMed Web of Science ®Google Scholar
• Shah MS, DeSantis TZ, Weinmaier T, et al. Leveraging sequence-based faecal microbial community survey data to identify a composite biomarker for colorectal cancer. Gut. 2018;67:882–891.
   PubMed Web of Science ®Google Scholar
• Flemer B, Warren RD, Barrett MP, et al. The oral microbiota in colorectal cancer is distinctive and predictive. Gut. 2018;67:1454–1463.
   PubMed Web of Science ®Google Scholar
• Uchino Y, Goto Y, Konishi Y, et al. Colorectal cancer patients have four specific bacterial species in oral and gut microbiota in common—A metagenomic comparison with healthy subjects. Cancers (Basel). 2021;13:13.
   Web of Science ®Google Scholar
• Flanagan L, Schmid J, Ebert M, et al. Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome. Eur J Clin Microbiol Infect Dis. 2014;33:1381–1390.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang Y, Gui X, et al. Salivary Fusobacterium nucleatum serves as a potential biomarker for colorectal cancer. iScience. 2022;25:104203.
   PubMed Web of Science ®Google Scholar
• Komiya Y, Shimomura Y, Higurashi T, et al. Patients with colorectal cancer have identical strains of Fusobacterium nucleatum in their colorectal cancer and oral cavity. Gut. 2019;68:1335–1337.
   PubMed Web of Science ®Google Scholar
• Richardson M, Ren J, Rubinstein MR, et al. Analysis of 16S rRNA genes reveals reduced Fusobacterial community diversity when translocating from saliva to GI sites. Gut Microbes. 2020;12:1–13.
   PubMed Web of Science ®Google Scholar
• Rubinstein MR, Wang X, Liu W, et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013;14:195–206.
   PubMed Web of Science ®Google Scholar
• Bullman S, Pedamallu CS, Sicinska E, et al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science. 2017;358:1443–1448.
   PubMed Web of Science ®Google Scholar
• Abed J, Emgard JE, Zamir G, et al. Fap2 mediates Fusobacterium nucleatum colorectal adenocarcinoma enrichment by binding to tumor-expressed gal-GalNAc. Cell Host Microbe. 2016;20:215–225.
   PubMed Web of Science ®Google Scholar
• Yu T, Guo F, Yu Y, et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell. 2017;170:548–563 e516.
   PubMed Web of Science ®Google Scholar
• Okumura S, Konishi Y, Narukawa M, et al. Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion. Nat Commun. 2021;12:5674.
   PubMed Web of Science ®Google Scholar
• Koren O, Spor A, Felin J, et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci U S A. 2011;108 Suppl 1:4592–4598.
   PubMed Web of Science ®Google Scholar
• Bulgart HR, Neczypor EW, Wold LE, et al. Microbial involvement in Alzheimer disease development and progression. Mol Neurodegener. 2020;15:42.
   PubMed Web of Science ®Google Scholar
• Silva MVF, Loures CMG, Alves LCV, et al. Alzheimer’s disease: risk factors and potentially protective measures. J Biomed Sci. 2019;26:33.
   PubMed Web of Science ®Google Scholar
• Giovannini MG, Lana D, Traini C, et al. The microbiota-gut-brain axis and Alzheimer disease. from dysbiosis to neurodegeneration: focus on the central nervous system glial cells. J Clin Med. 2021:10. DOI:10.3390/jcm10112358.
   Google Scholar
• De la Fuente M. The role of the microbiota-gut-brain axis in the health and illness condition: a focus on alzheimer’s disease. J Alzheimer’s Disease: JAD. 2021;81:1345–1360.
   PubMed Web of Science ®Google Scholar
• Lin C, Zhao S, Zhu Y, et al. Microbiota-gut-brain axis and toll-like receptors in Alzheimer’s disease. Comput Struct Biotechnol J. 2019;17:1309–1317.
   PubMed Web of Science ®Google Scholar
• Kohler CA, Maes M, Slyepchenko A, et al. The gut-brain axis, including the microbiome, leaky gut and bacterial translocation: mechanisms and pathophysiological role in alzheimer’s disease. Curr Pharm Des. 2016;22:6152–6166.
   PubMed Web of Science ®Google Scholar
• Maitre Y, Micheneau P, Delpierre A, et al. Did the brain and oral microbiota talk to each other? A review of the literature. J Clin Med. 2020:9. DOI:10.3390/jcm9123876.
   Google Scholar
• Parra-Torres V, Melgar-Rodriguez S, Munoz-Manriquez C, et al. Periodontal bacteria in the brain-Implication for Alzheimer’s disease: a systematic review. Oral Dis. 2023;29:21–28.
   PubMed Web of Science ®Google Scholar
• Narengaowa KW, Lan F, Awan UF, Qing H, Ni J The oral-gut-brain AXIS: the Influence of microbes in alzheimer’s disease. Front Cell Neurosci 2021: 15: 633735.
   Google Scholar
• Chen L, Xu X, Wu X, et al. A comparison of the composition and functions of the oral and gut microbiotas in Alzheimer’s patients. Front Cell Infect Microbiol. 2022;12:942460.
   PubMed Web of Science ®Google Scholar
• Yan C, Diao Q, Zhao Y, et al. Fusobacterium nucleatum infection-induced neurodegeneration and abnormal gut microbiota composition in Alzheimer’s disease-like rats. Front Neurosci. 2022;16:884543.
   PubMed Web of Science ®Google Scholar
• Chi L, Cheng X, Lin L, et al. Porphyromonas gingivalis-induced cognitive impairment is associated with gut dysbiosis, neuroinflammation, and glymphatic dysfunction. Front Cell Infect Microbiol. 2021;11:755925.
   PubMed Web of Science ®Google Scholar